Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Dolby Laboratories, Inc. | exhibit321-fy18q4.htm |
| EX-31.2 - EXHIBIT 31.2 - Dolby Laboratories, Inc. | exhibit312-fy18q4.htm |
| EX-31.1 - EXHIBIT 31.1 - Dolby Laboratories, Inc. | exhibit311-fy18q4.htm |
| EX-21.1 - EXHIBIT 21.1 - Dolby Laboratories, Inc. | exhibit211-fy18q4.htm |
| 10-K - 10-K: FY'18 Q4 - Dolby Laboratories, Inc. | a10-kfy18q4.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Dolby Laboratories, Inc.:
Dolby Laboratories, Inc.:
We consent to the incorporation by reference in the registration statements (Nos. 333-122908, 333-150804, 333-174319, 333-188602, 333-202012, and 333-216058) on Form S-8 of Dolby Laboratories, Inc. of our report dated November 16, 2017, with respect to the consolidated balance sheets of Dolby Laboratories, Inc. and subsidiaries as of September 29, 2017 and September 30, 2016, and the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended September 29, 2017, and the effectiveness of internal control over financial reporting as of September 29, 2017, which report appears in the September 29, 2017 annual report on Form 10-K of Dolby Laboratories, Inc.
/s/ KPMG LLP
San Francisco, California
November 14, 2018